Heartland Bank & Trust’s Pfizer PFE Stock Holding History

Heartland Bank & Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$523K	Sell	21,716 -230	-1%	-$6.02K	0.11%	135
2026 Q1	$616K	Buy	+21,946	New	+$584K	0.14%	112
2025 Q4	–	Sell	-21,669	Closed	-$552K	–	172
2025 Q3	$552K	Buy	21,669 +1,012	+5%	+$25K	0.23%	97
2025 Q2	$501K	Sell	20,657 -2,054	-9%	-$47.9K	0.23%	99
2025 Q1	$575K	Buy	+22,711	New	+$594K	0.3%	81
2024 Q4	–	Sell	-23,068	Closed	-$668K	–	158
2024 Q3	$668K	Buy	23,068 +1,777	+8%	+$51.8K	0.36%	68
2024 Q2	$596K	Buy	+21,291	New	+$586K	0.34%	69
2024 Q1	–	Sell	-13,860	Closed	-$399K	–	150
2023 Q4	$399K	Buy	13,860 +5,409	+64%	+$164K	0.27%	87
2023 Q3	$280K	Buy	+8,451	New	+$299K	0.22%	110
2023 Q2	–	Sell	-5,001	Closed	-$204K	–	133
2023 Q1	$204K	Buy	+5,001	New	+$216K	0.15%	132
2022 Q4	–	Sell	-13,882	Closed	-$607K	–	146
2022 Q3	$607K	Sell	13,882 -11,968	-46%	-$582K	0.58%	54
2022 Q2	$1.35M	Buy	25,850 +878	+4%	+$44.7K	1.2%	17
2022 Q1	$1.29M	Buy	24,972 +3,012	+14%	+$156K	0.98%	24
2021 Q4	$1.3M	Sell	21,960 -15,459	-41%	-$766K	0.96%	27
2021 Q3	$1.61M	Buy	37,419 +988	+3%	+$43.8K	1.39%	18
2021 Q2	$1.43M	Buy	+36,431	New	+$1.42M	1.31%	20

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Heartland Bank & Trust's PFE Position: Q2 2026 in Review

Heartland Bank & Trust reduced its Pfizer (PFE) stake by 1% in Q2 2026, selling an estimated $6.02K and leaving 21,716 shares worth $523K. The position accounts for 0.11% of the portfolio, ranked #135.

Heartland Bank & Trust first reported a position in PFE in Q2 2021 and has held it in 16 quarters since. The position peaked at $1.61M in Q3 2021. 2,836 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Heartland Bank & Trust held 21,716 shares of Pfizer worth $523K as of Q2 2026.
Heartland Bank & Trust sold 230 Pfizer shares in Q2 2026, an estimated $6.02K.
Pfizer made up 0.11% of Heartland Bank & Trust's portfolio in Q2 2026, its #135 holding.
Heartland Bank & Trust first reported a position in Pfizer in Q2 2021 and has held it in 16 quarters since.
Heartland Bank & Trust's Pfizer position peaked at $1.61M in Q3 2021.
2,836 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Heartland Bank & Trust's 13F filing for Q2 2026, filed 12 Aug 2026.